H.R. 2650 (104th): Mandatory Federal Prison Drug Treatment Act of 1995

104th Congress, 1995–1996. Text as of Jun 05, 1996 (Referred to Senate Committee).

Status & Summary | PDF | Source: GPO

HR 2650 RFS

104th CONGRESS

2d Session

H. R. 2650

IN THE SENATE OF THE UNITED STATES

June 5, 1996

Received; read twice and referred to the Committee on the Judiciary


AN ACT

To amend title 18, United States Code, to eliminate certain sentencing inequities for drug offenders.

    Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ‘Mandatory Federal Prison Drug Treatment Act of 1996’.

SEC. 2. ELIMINATION OF SENTENCING INEQUITIES FOR DRUG OFFENDERS.

    (a) IN GENERAL- Subparagraph (B) of section 3621(e)(2) of title 18, United States Code, is amended to read as follows:

        ‘(B) ADMINISTRATION OF TREATMENT PROGRAMS- The Attorney General shall ensure through the use of all appropriate and available incentives and sanctions that eligible prisoners undergo a program of substance abuse treatment.’.

    (b) CONFORMING AMENDMENT- The heading for paragraph (2) of section 3621(e) of title 18, United States Code, is amended by striking ‘INCENTIVE FOR PRISONERS’ SUCCESSFUL COMPLETION OF TREATMENT PROGRAM’ and inserting ‘TREATMENT REQUIREMENT’.

    (c) ELIGIBILITY- Clause (ii) of section 3621(e)(5)(B) of title 18, United States Code, is amended to read as follows:

          ‘(ii) within 24 months of the date of release, or is otherwise designated by the Bureau of Prisons for participation in a residential substance abuse treatment program; and’.

Passed the House of Representatives June 4, 1996.

Attest:

ROBIN H. CARLE,

Clerk.